• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by LifeStance Health Group Inc. (Amendment)

    2/13/23 4:31:10 PM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email
    SC 13G/A 1 d444809dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    LifeStance Health Group, Inc.

    (Name of Issuer)

    Common stock, par value $0.01 per share

    (Title of Class of Securities)

    53228F101

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐

    Rule 13d-1(b)

     

    ☐

    Rule 13d-1(c)

     

    ☒

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


      1.    

      Names of Reporting Persons

     

      Michael K. Lester

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5.     

      Sole Voting Power

     

      19,993,012

       6.   

      Shared Voting Power

     

      0

       7.   

      Sole Dispositive Power

     

      19,993,012

       8.   

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      19,993,012

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      5.3% (1)

    12.  

      Type of Reporting Person (See Instructions)

     

      IN

     

    1

    Calculated based on 375,986,406 shares of common stock, par value $0.01 per share outstanding as of November 1, 2022 as reported on the Issuer’s 10-Q, filed on November 9, 2022.


    SCHEDULE 13G

    Item 1.

     

      (a)

    Name of Issuer

    LifeStance Health Group, Inc., Delaware corporation (the “Issuer”)

     

      (b)

    Address of Issuer’s Principal Executive Offices

    4800 N. Scottsdale Road, Suite 6000, Scottsdale, Arizona 85251

    Item 2.

     

      (a)

    Name of Person Filing

    This Schedule 13G is being filed on behalf of Michael K. Lester

     

      (b)

    Address of Principal Business Office or, if none, Residence

    The address of the principal business office of the Reporting Person is 4800 N. Scottsdale Road, Suite 6000, Scottsdale, Arizona 85251.

     

      (c)

    Citizenship

    United States

     

      (d)

    Title of Class of Securities

    Common stock, par value $0.01 per share (the “Common Stock”)

     

      (e)

    CUSIP Number

    53228F101

     

    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    This Item 3 is not applicable.

     

    Item 4.

    Ownership

     

    (a)

    Amount beneficially owned:

    As of the date hereof, the Reporting Person beneficially owns 19,993,012 shares of Common Stock, representing approximately 5.3% of the outstanding shares of Common Stock.

    The percentage of the outstanding shares of Common Stock held by the Reporting Person is based on 375,986,406 shares of Common Stock issued and outstanding as of November 1, 2022 as reported on the Issuer’s 10-Q, filed on November 9, 2022.

     

    (b)

    Percent of class:

    See Item 4(a) hereof.


    (c)

    Number of shares as to which the person has:

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    This Item 5 is not applicable.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    None.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

    This Item 7 is not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group

    This Item 8 is not applicable.

     

    Item 9.

    Notice of Dissolution of Group

    This Item 9 is not applicable.

     

    Item 10.

    Certification

    This Item 10 is not applicable.


    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 13, 2023

     

    By:  

    /s/ Michael Lester

      Name: Michael Lester
    Get the next $LFST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    5/27/2025$8.50Neutral → Buy
    UBS
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    More analyst ratings

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LifeStance Health Group upgraded by UBS with a new price target

      UBS upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $8.50

      5/27/25 9:06:20 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

      KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

      4/8/25 9:29:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on LifeStance Health Group with a new price target

      Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

      4/3/25 8:18:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care